Basic Research

IGF-1 C Domain–Modified Hydrogel Enhances Cell Therapy for AKI

Feng, Guowei^*,†,‡; Zhang, Jimin^†; Li, Yang^*; Nie, Yan^*; Zhu, Dashuai^*; Wang, Ran^*; Liu, Jianfeng^§; Gao, Jie^†; Liu, Na^†; He, Ningning^*; Du, Wei^*; Tao, Hongyan^*; Che, Yongzhe^*; Xu, Yong^‡; Kong, Deling^†; Zhao, Qiang^†; Li, Zongjin^*,†

Author Information

^*School of Medicine and

^†State Key Laboratory of Medicinal Chemical Biology, Key Laboratory of Bioactive Materials, Ministry of Education, College of Life Sciences, Nankai University, Tianjin, China;

^‡Department of Urology, Second Hospital of Tianjin Medical University, Tianjin Institute of Urology, Tianjin, China; and

^§Tianjin Key Laboratory of Molecular Nuclear Medicine, Institute of Radiation Medicine, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin, China

Correspondence: Dr. Zongjin Li or Dr. Qiang Zhao, Nankai University, 94 Weijin Road, Tianjin 300071, China, or Dr. Yong Xu, Department of Urology, Second Hospital of Tianjin Medical University, Tianjin Institute of Urology, 22 Pingjiang Road, Tianjin 300211 China. Email: [email protected], [email protected], or [email protected]

Journal of the American Society of Nephrology 27(8):p 2357-2369, August 2016. | DOI: 10.1681/ASN.2015050578